Effexor - Drug Details
📊 Estimates Effexor Dialyzability By Different_Modalities

Effexor

Complete Drug Information

Drug Name
Effexor
Trade Names
Effexor
Pregnancy Category
AU: B2
Bioavailability
42±15%
Routes of Administration
Oral
Protein Binding
27±2% (parent compound), 30±12% (active metabolite, desvenlafaxine)%
Metabolism
Extensively metabolised by the liver, primarily via CYP2D6
Elimination
5±2 h (parent compound for immediate release preparations), 15±6 h (parent compound for extended-release preparations), 11±2 h (active metabolite)
Excretion
Kidney (87%; 5% as unchanged drug; 29% as desvenlafaxine and 53% as other metabolites)
Formula
C17H27NO2
Molar Mass
277.408
Drug Class
Serotonin–norepinephrine reuptake inhibitor
Volume of Distribution
C17H27NO2

🤰 Pregnancy Category Information

Category: AU: B2

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.